Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

58.70
Delayed Data
As of Aug 04
 -0.35 / -0.59%
Today’s Change
52.49
Today|||52-Week Range
63.62
+3.36%
Year-to-Date
Merck (MRK) Stock Price Target Increased at Leerink
Aug 04 / TheStreet.com
Merck Tops on Q2 Earnings & Revenues, Revises Outlook - Analyst Blog
Jul 28 / Zacks.com
3 Drugs Stocks Dragging The Industry Down
Aug 04 / TheStreet.com
The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmace...
Jul 28 / Zacks.com
Big Pharma Tops Q1 Earnings & Revenue: ETFs in Focus - ETF News And Commentary
Aug 04 / Zacks.com
Merck (MRK) Tops on Q2 Earnings & Revenues - Tale of the Tape
Jul 28 / Zacks.com
Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible'
Aug 01 / TheStreet.com
4 Stocks to Fight the Virus on World Hepatitis Day - Analyst Blog
Jul 27 / Zacks.com
5 Key Points You May Have Missed in Merck's Q2 Report
Jul 31 / MotleyFool.com
Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings ...
Jul 27 / Zacks.com
Dow 30 Stock Roundup: Pfizer, P&G, Merck Beat on Earnings, DuPont Misses Estimates - ...
Jul 31 / Zacks.com
3 Important Questions We Want Answered When Merck Reports Its Q2 Results
Jul 27 / MotleyFool.com
Bayer (BAYRY) Q2 Revenues Up Y/Y, 2015 Guidance Revised - Analyst Blog
Jul 30 / Zacks.com
Upbeat Reckitt raises growth forecast on better consumer sentiment
Jul 27 / FT.com
Price Isn't a Problem for Gilead Sciences
Jul 30 / TheStreet.com
Companies diary: July 27 - July 31
Jul 26 / FT.com
Price Isn't a Problem for Gilead Sciences
Jul 30 / TheStreet.com
Earnings Growth Hard to Come By - Earnings Preview
Jul 24 / Zacks.com
Trade-Ideas: Merck (MRK) Is Today's "Storm The Castle" Stock
Jul 29 / TheStreet.com
Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog
Jul 24 / Zacks.com
3 Stocks Driving The Drugs Industry Higher
Jul 29 / TheStreet.com
Merck's Anti-PD-1 Therapy Melanoma Drug Gets EU Nod - Analyst Blog
Jul 23 / Zacks.com
Company News for July 29, 2015 - Corporate Summary
Jul 29 / Zacks.com
Drugmakers premiere summer blockbusters
Jul 12 / FT.com